% | $
Quotes you view appear here for quick access.

Threshold Pharmaceuticals Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • tredleon tredleon Apr 10, 2007 7:12 PM Flag

    Anyone have on-line WSJ story that mentions this stock?

    I'm sure they are just saying that THLD's end-stage trial with Glufo in pancreatic cancer recently failed and the company has a similar trial (as the Erbitux trial) with Glufo+Gemzar underway as a first-line treatment - what more could they say, except that pancreatic cancer is brutal?

3.80-0.07(-1.81%)Nov 25 4:00 PMEST